Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 22 Uterine Cervical Neoplasms 13 Prostatic Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Rectal Neoplasms 8 Pancreatic Neoplasms 8 Lymphoma 8 Carcinoma, Non-Small-Cell Lung 8 Anxiety Disorders 8 Obesity 7 Hematologic Neoplasms 7 Depression 7 Vulvar Neoplasms 6 Melanoma 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Breast Carcinoma In Situ 6 Urinary Bladder Neoplasms 5 Pain 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Fatigue 4 Carcinoma, Ovarian Epithelial 4 Vaginal Neoplasms 3

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Analgesics, Opioid 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡